Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05425940
Title	Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer (STELLAR-303)
Acronym	STELLAR-303
Recruitment	Active, not recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Exelixis
Indications	colon adenocarcinoma rectum adenocarcinoma
Therapies	Atezolizumab + XL092 Regorafenib
Age Groups:	senior \| adult
Covered Countries	USA \| POL \| NZL \| HUN \| GBR \| FRA \| ESP \| DEU \| BEL \| AUS